Patent details
EP3102212
Title:
CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
Basic Information
- Publication number:
- EP3102212
- PCT Application Number:
- NL2014050068
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP147052252
- PCT Publication Number:
- WO2015119495
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CHOLESTERYL ESTER TRANSFER PROTEIN (CETP) INHIBITOR AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID INHIBITOR FOR USE IN THE TREATMENT OR PREVENTION OF CARDIOVASCULAR DISEASES
- French Title of Invention:
- INHIBITEUR DE LA PROTÉINE DE TRANSFERT D'ESTER DE CHOLESTÉRYLE (CETP) ET COMPOSITIONS PHARMACEUTIQUES COMPRENANT LEDIT INHIBITEUR POUR LEUR UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION DE MALADIES CARDIOVASCULAIRES
- German Title of Invention:
- CHOLESTERYLESTERTRANSFERPROTEIN (CETP)-INHIBITOR UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT DIESEN INHIBITOR ZUR BEHANDLUNG ODER PRÄVENTION VON KARDIOVASKULÄREN ERKRANKUNGEN
- SPC Number:
-
Dates
- Filing date:
- 05/02/2014
- Grant date:
- 07/11/2018
- EP Publication Date:
- 14/12/2016
- PCT Publication Date:
- 13/08/2015
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/11/2018
- EP B1 Publication Date:
- 07/11/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 05/02/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 23/02/2022
-
-
- Name:
- NewAmsterdam Pharma B.V.
- Address:
- Gooimeer 2-35, 1411 DC, Naarden, Netherlands (NL)
History of Owners
- From:
- 31/10/2018
- To:
- 23/02/2022
- Name:
- Dezima Pharma B.V.
- Address:
- Minervum 7061, 4817 ZK Breda, Netherlands (NL)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 30/01/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- TOMIYASU, Koichi
- Address:
- Japan (JP)
2
- Name:
- FORD, John
- Address:
- United Kingdom (GB)
3
- Name:
- KAWAGUCHI, Atsuhiro
- Address:
- Japan (JP)
4
- Name:
- OKA, Kozo
- Address:
- Japan (JP)
5
- Name:
- ROUND, Patrick
- Address:
- United Kingdom (GB)
6
- Name:
- KASTELEIN, John
- Address:
- Netherlands (NL)
Classification
- IPC classification:
-
A61K 31/506;
A61P 3/06;
A61P 9/00;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2022/04
- Publication date:
- 04/03/2022
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
- Issue number:
- 201845
- Publication date:
- 07/11/2018
- Description:
- Grant (B1)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name/address
- Deed Number:
- RC20220000058A
- Date Registered:
- 23/02/2022
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
OFFICE FREYLINGER S.A.
- Journal Edition Number:
-
- Text:
- Change of owners name and address
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Added Owner(s)
- Name:
- NewAmsterdam Pharma B.V.
- Address:
- Gooimeer 2-35, 1411 DC, Naarden, Netherlands (NL)
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
- 02/03/2026
- Annual Fee Number:
- 13
- Annual Fee Amount:
- 180 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 25/03/2025
- Last Annual Fee Paid Number:
- 12
- Last Annual Fee Paid Amount:
- 165 Euro
- Payer:
- IPAN GMBH